Literature DB >> 30833187

Impact of narrow margin and R1 resection for hepatocellular carcinoma on the salvage liver transplantation strategy. An intention-to-treat analysis.

Chetana Lim1, Chady Salloum1, Eylon Lahat2, Dobromir Sotirov1, Rony Eshkenazy2, Chaya Shwaartz2, Daniel Azoulay3.   

Abstract

BACKGROUND: No studies have investigated whether narrow margin is a risk factor for hepatocellular carcinoma recurrence outside transplantability criteria. The objective was to assess on an intent-to-treat (ITT) basis whether hepatectomy with narrow margin affects the outcomes in patients enrolled in the salvage liver transplantation (LT) strategy.
METHODS: From 2007 to 2016, patients enrolled in the salvage LT strategy were divided into 2 groups: narrow (<10 mm) vs. wide (≥10 mm) margin groups. R1 resection was defined as positive histologic margin involvement. Recurrence rate, transplantability rate of recurrence and ITT overall survival (ITT-OS) were evaluated.
RESULTS: A total of 81 patients were studied: 43 patients with narrow margin and 38 with wide margin. The recurrence rates, pattern and delay of recurrence, transplantability following recurrence, and ITT-OS were similar between the two groups. These results were maintained when comparing patients with R1 resection to those with R0 resection.
CONCLUSION: On an ITT basis, hepatectomy with narrow margin or R1 resection did not impair the transplantability of recurrence and survival of patients enrolled in the salvage LT strategy. Narrow margin and even R1 resection following hepatectomy in the setting of salvage LT strategy should not be the basis for altering the strategy.
Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 30833187     DOI: 10.1016/j.hpb.2019.02.001

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  2 in total

1.  Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.

Authors:  Chetana Lim; Claire Goumard; Margarida Casellas-Robert; Santiago Lopez-Ben; Laura Lladó; Juli Busquets; Chady Salloum; Maria Teresa Albiol-Quer; Ernest Castro-Gutiérrez; Olivier Rosmorduc; Cyrille Feray; Emilio Ramos; Joan Figueras; Olivier Scatton; Daniel Azoulay
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

2.  lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma.

Authors:  Siyao Wu; Yayan Deng; Yue Luo; Jiaxiang Ye; Zhihui Liu
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.